Harvey Reiser, MD
Ophthalmology · Kingston, PANPI 1376502229
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (52.3%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Alcon accounts for 89.5% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2022 at $2,775 and has fallen 88.4% since, to $323 in 2025.
Across 59 payments — averaging $112.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$6K
- Carl Zeiss Meditec USA, Inc.$175
- Rxsight Inc$128
- Glaukos Corporation$108
- Bausch & Lomb, A Division Of Bausch Health US, LLC$100
- Carl Zeiss Meditec, Inc.$91
- plus $99 from 4 others
Across 126 payments — averaging $5181.41 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Johnson & Johnson Surgical Vision, Inc.$446K
- Alcon Research LLC$88K
- Novartis$83K
- Kala Pharmaceuticals, Inc.$27K
- Sun Pharmaceutical Industries Inc.$8K
What the payments were for
- Consulting fees$2,45037%
- Travel & lodging$71911%
- Food & beverage$3,47752%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 47 | $5,945 |
| Carl Zeiss Meditec USA, Inc. | 2 | $175 |
| Rxsight Inc | 1 | $128 |
| Glaukos Corporation | 1 | $108 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $100 |
| Carl Zeiss Meditec, Inc. | 2 | $91 |
| Ocular Therapeutix, Inc. | 2 | $39 |
| NEW World Medical,inc. | 1 | $25 |
| Omeros Corporation | 1 | $18 |
| Rayner Intraocular Lenses Limited | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Clareon$2,648
- AcrySof$584
- AcrySof IQ VIVITY IOL$350
- AcrySof IQ PanOptix UV IOL$276
- VisuMax$150
- ORA System VerifEye$137
- ReSTOR$132
- RXSIGHT CONTACT LENS$128
- RXSIGHT INJECTOR HANDPIECE$128
- RXSIGHT LIGHT DELIVERY DEVICE (LDD)$128
- RXSIGHT LIGHT ADJUSTABLE LENS (RXLAL)$128
- RXSIGHT INJECTOR CARTRIDGE$128
- Clareon PanOptix Pro$126
- PanOptix$123
- iStent inject Trabecular Micro-Bypass Stent System$108
- AcrySof IQ PanOptix$102
How this compares
$6,646 in reported general payments places this provider in the 85th percentile of 920 ophthalmology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Bromfenac Sodium | 22 | $2,258 |
| Prednisolone Acetate | 40 | $1,933 |
| Cyclosporine | 12 | $1,826 |
| Ketorolac Tromethamine | 31 | $551 |
| Latanoprost | 24 | $377 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Kingston
- Julia HallerPhiladelphia$1.5M
- Francis MahPittsburgh$1.1M
- Brandon AyresBala Cynwyd$929K
- David AlmeidaErie$734K
- Carl RegilloPlymouth Meeting$721K
- Robert NoeckerPittsburgh$632K
- Beeran MeghparaPhiladelphia$496K
- Michael KlufasPlymouth Meeting$393K
- Jonathan MyersPhiladelphia$359K
- Mark BlecherPhiladelphia$357K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.